Akt (Protein Kinase B) Inhibitors


Akt, also known as protein kinase B (PKB), a serine/ threonine kinase, is a critical enzyme in several signal transduction pathways involved in cell proliferation, apoptosis, angiogenesis, and diabetes. Four different isoforms of Akt (a, b1, b2, and g) have been reported that differ slightly in the localization of their regulatory phosphorylation sites. Activation of Akt involves growth factor binding to a receptor tyrosine kinase and activation of PI 3-K, which phosphorylates the membrane bound PI (4,5)P2 (PIP2) to generate PI(3,4,5)P3 (PIP3). Binding of PIP3 to Akt anchors it to the plasma membrane and exposes it to phosphorylation and activation by 3-phosphoinositidedependent kinase-1 (PDK1). Akt is activated following its phosphorylation at two regulatory residues, a threonine residue on the kinase domain and a serine residue on the hydrophobic motif, which are structurally and functionally conserved within the AGC kinase family. Phosphorylation of threonine on the kinase domain, catalyzed by PDK1, is essential for Akt activation. Akt activity is augmented approximately 10-fold by phosphorylation at the serine on the hydrophobic motif by PDK2. Phosphorylation of Thr308 and Ser473 activates Akt a. Phosphorylation at Thr309 and Ser474 on Akt b1 and b2, and on Thr305 on Akt g result in their activation. The activation of Akt is negatively regulated by PTEN, a PIP3 specific phosphatase, and SHIP, an SH2-domain containing inositol 5-phosphatase.

The identification of Akt as a key regulator of cellular survival has significant implications for oncogenesis. A number of oncogenes and tumor suppressor genes that function upstream of Akt influence cancer progression by regulating Akt. The principal role of Akt in the cell is to facilitate growth factor-mediated cell survival and to block apoptotic cell death. This is achieved by phosphorylating and deactivating pro-apoptotic factors such as BAD, Caspase-9, and Forkhead transcription factors (FKHR). The phosphorylation of BAD allows it to bind to 14-3-3 protein thereby preventing localization of BAD at the mitochondria to induce apoptosis. Additionally, phosphorylation of FKHR by Akt prevents it from inducing expression of Fas ligand; hence it promotes cell survival. Akt also phosphorylates and activates IKKa, which leads to NF-kB activation and cell survival. Akt is also known to stimulate glycogen synthesis by phosphorylating and inactivating GSK-3 leading to the activation of glycogen synthase. The inactivation of GSK-3 also induces the up-regulation of cyclin D, which enhances cell cycle progression. Akt is reported to play a critical role in tumorigenesis, becoming activated when tumor suppressors such as p27Kip1 and PTEN lose their functions. Phosphorylation of p27 at Thr157 by Akt impairs its nuclear import and leads to its cytoplasmic accumulation. Cytoplasmic mislocalization of p27 has been strongly linked to loss of differentiation and poor outcome in breast cancer patients. Akt can also physically associate with endogenous p21, a cell cycle inhibitor, and phosphorylate it at Thr145, causing its localization to the cytoplasm, ultimately resulting in deregulation of cell proliferation.

Lindsley, C.W. 2010. Curr. Topics Med. Chem. 10, 458.  Feng, J. et al. 2004. J. Biol. Chem. 279, 41189.  Cantley, L.C. 2002. Science 296, 1655.  Graff, J.R. 2002. Expert Opin. Ther. Targets 6, 104.  Liang, J., et al. 2002. Nat. Med. 8, 1153.  Mitsiades, C.S., et al. 2002. Oncogene 21, 5673.  Shiojima, I., and Walsh, K. 2002. Circ. Res. 90, 1243.  Yang, J., et al. 2002. Nat. Struct. Biol. 9, 940.  Zhou, B.P., and Hung, M.C. 2002. Semin. Oncol. 29, 62.  El-Deiry, W.S. 2001. Nat. Cell Biol. 3, E71.  Martin, D., et al. 2001. J. Neurochem. 78, 1000.  Sabbatini P., and McCormick, F. 1999. J. Biol. Chem. 274, 24263.

Highlighted below are inhibitors included in InhiibtorSelect™ Akt/PI 3-K/mTor Signaling Pathway Inhibitor Panel:

Click image to enlarge.
InhibitorSelect™ Akt/PI 3-K/mTor Signaling Pathway Inhibitor Panel

Products in this category:
Catalog number Products
124005 Akt Inhibitor - Calbiochem 
124008 Akt Inhibitor II - Calbiochem 
124009 Akt Inhibitor III - Calbiochem 
124011 Akt Inhibitor IV - CAS 681281-88-9 - Calbiochem 
124019 Akt Inhibitor IX, API-59CJ-OMe - CAS 98510-80-6 - Calbiochem 
124013 Akt Inhibitor VI, Akt-in - Calbiochem 
124018 Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem 
124014 Akt Inhibitor VII, TAT-Akt-in - Calbiochem 
124012 Akt Inhibitor V, Triciribine - CAS 35943-35-2 - Calbiochem 
124020 Akt Inhibitor X - CAS 925681-41-0 - Calbiochem 
 Pages  1 2 3 4 Next  
... or select the first letter of the product name

© Merck KGaA, Darmstadt, Germany, 2014


Welcome to Merck Millipore


Europe, Middle East and Africa Asia / Pacific North America, Central America and the Caribbean South America

Please choose your country:

North America, Central America and the Caribbean

South America

Europe, Middle East and Africa

Asia / Pacific

All countries from A to Z

If you can't find your country please click here.


Privacy Statement



Merck Chemicals Cart ()

You are entering the Millipore online shop. Both carts are maintained for you while you shop between sites. We recommend to complete your Merck order before visiting

Go to Millipore Proceed to checkout

What kind of products are you looking for?


Bio manufacturing and Life science.

Merck Chemicals

High-quality industrial and laboratory chemicals.

Important message

It is currently not possible to order Bioscience products together with other Merck products. We recommend completing your current order first.

Do you wish to proceed without completing your current order? If so, this will empty your shopping cart.